Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

USBC, Inc. Director's Dealing 2022

Jun 13, 2022

33069_dirs_2022-06-13_b8ea711d-b33a-429e-bde1-1172f4f7e73e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: KNOW LABS, INC. (KNWN)
CIK: 0001074828
Period of Report: 2022-06-10

Reporting Person: Trautwein Leonardo Mouta (Chief Marketing Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-06-10 Common Stock P 10000 $1.65 Acquired 13980 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Option to Purchase Common Stock $2.04 2026-02-04 Common Stock (200000) 200000 Direct
Option to Purchase Common Stock $2.35 2026-02-09 Common Stock (100000) 100000 Direct
Option to Purchase Common Stock $2.09 2026-12-16 Common Stock (100000) 100000 Direct
Option to Purchase Common Stock $1.48 2027-05-20 Common Stock (600000) 600000 Direct

Footnotes

F1: Options vest quarterly over four years. No vesting during first 6 months.

F2: Options vest upon FDA approval

F3: Options vest quarterly over four years.